Imugene’s ‘holy grail’ cancer therapy taken to USA
SYDNEY: ASX-listed immuno-oncology company Imugene has penned a licensing patent deal with the California-based cancer
SYDNEY: ASX-listed immuno-oncology company Imugene has penned a licensing patent deal with the California-based cancer
FEATURED
Nursing home ownership moves represent major risk to future survival of sector
Senior living company announces raising millions in seed funding
Complex will provide intergenerational community for young mothers and seniors
Best retirement housing design for Global Awards shortlisted
4 KPIs that revealed senior housing as recession-resilient
Could modular homes solve intergenerational housing crisis?
INNOVATION
